metformin combination
Showing 1 - 25 of >10,000
Oral Leukoplakia Trial in Minneapolis (pioglitazone-metformin)
Not yet recruiting
- Oral Leukoplakia
-
Minneapolis, MinnesotaUniversity of Minnesota
Feb 4, 2023
Polycystic Ovary Syndrome, Obesity, Infertility, Female Trial (Liraglutide + Metformin, Metformin)
Not yet recruiting
- Polycystic Ovary Syndrome
- +2 more
- Liraglutide + Metformin
- Metformin
- (no location specified)
Jul 10, 2023
Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide
- Metformin Hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 4, 2022
Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg
Not yet recruiting
- Type2diabetes
- Insulin Resistance
- Metformin
- +2 more
- (no location specified)
Oct 20, 2022
Obesity, Childhood, Insulin Resistance Trial in Edmonton (Metformin 850 mg oral tablet bid, Supplemental fiber mixture (35 g
Recruiting
- Obesity, Childhood
- Insulin Resistance
- Metformin 850 mg oral tablet bid
- Supplemental fiber mixture (35 g total) composed of 6g of Oligofructose + 12g of resistant maltodextrin + 12g of acacia gum + 5g of PGX.
-
Edmonton, Alberta, CanadaUniversity of Alberta
Apr 1, 2022
PCO Trial in Peshawar (OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD), Metformin (1000 mg Twice a day))
Recruiting
- PCO
- OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD)
- Metformin (1000 mg Twice a day)
-
Peshawar, Khyber Pakhtunkhwa, PakistanGynecology and Obstetric, Hayatabad Medical Complex
Jul 19, 2023
Advanced Cancers Trial in Houston (Temsirolimus, Metformin)
Active, not recruiting
- Advanced Cancers
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Preeclampsia Severe, Preeclampsia Second Trimester, Preterm Birth Complication Trial in Newark (Esomeprazole 20mg)
Not yet recruiting
- Preeclampsia Severe
- +2 more
- Esomeprazole 20mg
-
Newark, DelawareChristiana Care Health Systems
Nov 2, 2022
Healthy Subjects Trial in Cheongju-si (DW6013)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
May 16, 2023
Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)
Active, not recruiting
- Breast Cancer
- +2 more
- Metformin
- +2 more
-
New York, New YorkColumbia University Medical Center - Herbert Irving Cancer Cente
Aug 16, 2022
Healthy Subjects Trial in Cheongju-si (DW6013)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
May 16, 2023
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +2 more
-
Jacksonville, Florida
- +1 more
Jan 5, 2023
Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Glucose, High Blood
-
Cheonju, Chungcheongbuk-do, Korea, Republic ofChungbuk National University Hospital
Jul 19, 2022
Type 2 Diabetes Trial in Beijing (Retagliptin phosphate tablets?metformin sustained-release tablets, Retagliptin phosphate
Recruiting
- Type 2 Diabetes
- Retagliptin phosphate tablets、metformin sustained-release tablets
- Retagliptin phosphate placebo tablets、metformin sustained-release tablets
-
Beijing, Beijing, ChinaBeijing Hospital
Jun 9, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory
Completed
- Advanced Malignant Solid Neoplasm
- +3 more
- Laboratory Biomarker Analysis
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 21, 2022
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial (DWP16001, Dapagliflozin Tablet)
Not yet recruiting
- Diabetes Mellitus
- +4 more
- DWP16001
- Dapagliflozin Tablet
- (no location specified)
Aug 16, 2022
Diabetes Trial in India (Canagliflozin + Metformin HCl (Fixed Dose Combination))
Completed
- Diabetes Mellitus
- Canagliflozin + Metformin hydrochloride (Fixed Dose Combination)
-
Bengaluru, India
- +9 more
Aug 16, 2022
Healthy Volunteer Trial in Suzhou (Dapagliflozin/metformin XR FDC 5/500 mg, Dapagliflozin/metformin XR FDC 10/1000 mg,
Completed
- Healthy Volunteer
- Dapagliflozin/metformin XR FDC 5/500 mg
- +3 more
-
Suzhou, ChinaResearch Site
Apr 25, 2022
Learn More About How Acarbose and Metformin Work When Taken
Recruiting
- Type 2 Diabetes Mellitus
- BAY81-9783 (Acarbose/Metformin)
-
Multiple Locations, IndiaMany locations
Aug 10, 2022
Diabetes, Type 2 Trial in Maysan Governorate (drug, combination product, other)
Completed
- Diabetes Mellitus, Type 2
- Metformin 500 mg/day
- +2 more
-
Maysan Governorate, IraqMaysan Centre for Diabetes and Endocrinology
Jun 15, 2023
Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)
Completed
- Malaria
- Midazolam
- +7 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Nov 2, 2022
Multiple Sclerosis Trial in Cambridge (Metformin and clemastine in combination, Placebo)
Recruiting
- Multiple Sclerosis
- Metformin and clemastine in combination
- Placebo
-
Cambridge, United KingdomAddenbrooke's Hospital
Jun 14, 2022
Uveitis, Metformin, Glucocorticoid Trial in Tianjin (Metformin, Placebo)
Recruiting
- Uveitis
- +2 more
- Metformin
- Placebo
-
Tianjin, Tianjin, ChinaTianjin Medical University Eye Hospital
May 5, 2022